Kloeckner Chemical Limited - Accounts to registrar (filleted) - small 17.3

Kloeckner Chemical Limited - Accounts to registrar (filleted) - small 17.3


IRIS Accounts Production v17.3.0.1062 04111394 Board of Directors 1.4.16 31.3.17 31.3.17 false true false false true false Ordinary class A 1.00000 Ordinary class B 1.00000 Preference Shares B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure041113942016-03-31041113942017-03-31041113942016-04-012017-03-31041113942015-03-31041113942015-04-012016-03-31041113942016-03-3104111394ns15:EnglandWales2016-04-012017-03-3104111394ns14:PoundSterling2016-04-012017-03-3104111394ns10:Director12016-04-012017-03-3104111394ns10:PrivateLimitedCompanyLtd2016-04-012017-03-3104111394ns10:SmallEntities2016-04-012017-03-3104111394ns10:AuditExempt-NoAccountantsReport2016-04-012017-03-3104111394ns10:SmallCompaniesRegimeForDirectorsReport2016-04-012017-03-3104111394ns10:SmallCompaniesRegimeForAccounts2016-04-012017-03-3104111394ns10:FullAccounts2016-04-012017-03-3104111394ns10:OrdinaryShareClass12016-04-012017-03-3104111394ns10:OrdinaryShareClass22016-04-012017-03-3104111394ns10:OrdinaryShareClass32016-04-012017-03-3104111394ns10:Director22016-04-012017-03-3104111394ns10:CompanySecretary12016-04-012017-03-3104111394ns10:RegisteredOffice2016-04-012017-03-3104111394ns5:CurrentFinancialInstruments2017-03-3104111394ns5:CurrentFinancialInstruments2016-03-3104111394ns5:ShareCapital2017-03-3104111394ns5:ShareCapital2016-03-3104111394ns5:CapitalRedemptionReserve2017-03-3104111394ns5:CapitalRedemptionReserve2016-03-3104111394ns5:RetainedEarningsAccumulatedLosses2017-03-3104111394ns5:RetainedEarningsAccumulatedLosses2016-03-3104111394ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-03-3104111394ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-03-3104111394ns10:OrdinaryShareClass12017-03-3104111394ns10:OrdinaryShareClass22017-03-3104111394ns10:OrdinaryShareClass32017-03-3104111394ns5:RetainedEarningsAccumulatedLosses2016-03-3104111394ns5:CapitalRedemptionReserve2016-03-3104111394ns5:RetainedEarningsAccumulatedLosses2016-04-012017-03-31


REGISTERED NUMBER: 04111394 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2017

for

Kloeckner Chemical Limited

Kloeckner Chemical Limited (Registered number: 04111394)






Contents of the Financial Statements
for the Year Ended 31 March 2017




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Kloeckner Chemical Limited

Company Information
for the Year Ended 31 March 2017







DIRECTORS: Dr D B Kruger
L Ranger





SECRETARY: P H Whiteside





REGISTERED OFFICE: 277-279 Chiswick High Road
Chiswick
London
W4 4PU





REGISTERED NUMBER: 04111394 (England and Wales)





ACCOUNTANTS: Freeman Carr
Chartered Certified Accountants
The Gatehouse
2 Devonhurst Place
Heathfield Terrace
Chiswick
London
W4 4JD

Kloeckner Chemical Limited (Registered number: 04111394)

Balance Sheet
31 March 2017

31.3.17 31.3.16
Notes £    £   
CURRENT ASSETS
Debtors 4 150 -
Investments 5 102,336 -
Cash at bank 316,013 479,544
418,499 479,544
CREDITORS
Amounts falling due within one year 6 13,650 5,900
NET CURRENT ASSETS 404,849 473,644
TOTAL ASSETS LESS CURRENT
LIABILITIES

404,849

473,644

CAPITAL AND RESERVES
Called up share capital 7 555,000 555,000
Capital redemption reserve 8 7,500 7,500
Retained earnings 8 (157,651 ) (88,856 )
SHAREHOLDERS' FUNDS 404,849 473,644

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and
387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the
company as at the end of each financial year and of its profit or loss for each financial year in
accordance with the requirements of Sections 394 and 395 and which otherwise comply with
the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.

Kloeckner Chemical Limited (Registered number: 04111394)

Balance Sheet - continued
31 March 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 25 September 2017 and
were signed on its behalf by:





Dr D B Kruger - Director


Kloeckner Chemical Limited (Registered number: 04111394)

Notes to the Financial Statements
for the Year Ended 31 March 2017

1. STATUTORY INFORMATION

Kloeckner Chemical Limited is a private company, limited by shares , registered in England
and Wales. The company's registered number and registered office address can be found
on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding
discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income
Statement, except to the extent that it relates to items recognised in other comprehensive
income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that
have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not
reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in
periods different from those in which they are recognised in financial statements. Deferred
tax is measured using tax rates and laws that have been enacted or substantively enacted
by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it
is probable that they will be recovered against the reversal of deferred tax liabilities or other
future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.17 31.3.16
£    £   
Other debtors 150 -

Kloeckner Chemical Limited (Registered number: 04111394)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2017

5. CURRENT ASSET INVESTMENTS
31.3.17 31.3.16
£    £   
Other 102,336 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.17 31.3.16
£    £   
Directors' current accounts 2,500 2,500
Accrued expenses 11,150 3,400
13,650 5,900

7. CALLED UP SHARE CAPITAL




Allotted, issued and fully paid:
Number: Class: Nominal 31.3.17 31.3.16
value: £    £   
5,000 Ordinary class A £1 5,000 5,000
5,000 Ordinary class B £1 - -
550,000 Preference Shares B £1 550,000 550,000
555,000 555,000

8. RESERVES
Capital
Retained redemption
earnings reserve Totals
£    £    £   

At 1 April 2016 (88,856 ) 7,500 (81,356 )
Deficit for the year (68,795 ) (68,795 )
At 31 March 2017 (157,651 ) 7,500 (150,151 )

9. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting
Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of
Ireland', not to disclose related party transactions with wholly owned subsidiaries within the
group.